The first-of-its-kind product, named KetoCitraTM, is based on breakthrough research by University of California Santa Barbara professor Dr. Thomas Weimbs, a recognized leader in the Polycystic Kidney Disease (PKD) research field, and Dr. Jacob Torres, Head Researcher of Santa Barbara Nutrients (SBN).
Santa Barbara, California – December 6th, 2021
Facebook
Linkedin
Twitter
Instagram
Youtube
The patented technology underlying KetoCitraTM was initially developed by Dr. Weimbs and Dr. Torres at the University of California, Santa Barbara. They discovered that a combination of two natural compounds – beta-hydroxybutyrate (BHB) and citrate – has a synergistic effect in halting or slowing the progression of PKD in animal models.
With kidney health and safety as a priority during the product’s development, SBN worked with a premier group of advisors that included some of the leading scientists, medical doctors, and dietitians in the renal field worldwide.
“The launch of KetoCitraTM is a seminal moment for both Santa Barbara Nutrients and PKD patients. Our focus is to bring hope to the millions of PKD patients around the world, and we think KetoCitraTM has the potential to achieve that,” said Dr. Weimbs, President and Founder of Santa Barbara Nutrients.
What is polycystic kidney disease?
PKD is one of the most common, life-threatening genetic diseases, causing kidney enlargement and function loss over time. The disease affects over 600,000 Americans and 13 million people worldwide and is one of the leading causes of kidney failure requiring dialysis or kidney transplantation. There is no cure.
About KetoCitra TM
The research by Dr. Weimbs and Dr. Torres showed that two natural compounds, beta-hydroxybutyrate (BHB) and citric acid (citrate), can help the nutritional management of PKD by addressing the metabolic abnormalities that manifest during the progression of the disease.
KetoCitraTM is specifically designed with these two ingredients in a formulation that also delivers beneficial minerals and an alkaline load intended to support the balancing of urine pH. The inclusion of calcium and magnesium helps to manage the dietary absorption of the renal stressors oxalate and inorganic phosphate.
KetoCitraTM uses only ingredients that are generally recognized as safe (GRAS), is sodium- and sugar-free and formulated to be kidney-safe when used as directed. As a medical food, KetoCitraTM is to be taken under medical supervision. KetoCitraTM can be taken by itself but is recommended to be taken in conjunction with specific dietary and lifestyle changes. Researchers at SBN have collaborated with experienced renal dietitians to create a dietary program called Ren.Nu that is administered by the non-profit RenAlign. Patients in the Ren.Nu program, which launches in January 2022, learn to implement a plant-focused, kidney-safe ketogenic diet, together with KetoCitraTM, in a sustainable way.
About Santa Barbara Nutrients, Inc.
Santa Barbara Nutrients is a public benefit corporation incorporated in Delaware and headquartered in Santa Barbara, California. The experienced SBN team is composed of kidney researchers, patients, and other industry professionals dedicated to bringing to market novel medical foods and other innovative products to help people with PKD and other renal diseases.
The company is committed to scientific and clinical research to develop science backed products that support human health and address significant unmet medical needs.
For more information, please visit www.SantaBarbaraNutrients.com
Want to read more? https://www.news.ucsb.edu/2021/020480/ketocitra-here
Contact:
Email: Info@SantaBarbaraNutrients.com
Phone: 1+805-272-0029
Santa Barbara, California – April 27th, 2023 Santa Barbara Nutrients (SBN) is delighted to announce the appointment of Jessianna Saville to SBN’s advisory board, where she will bring her 17 years of renal nutrition experience as well as knowledge of building and...
Santa Barbara, California – May 22th, 2023 Santa Barbara Nutrients (SBN) is delighted to announce the appointment of Mr. Gregg Betz as Chief Executive Officer. With over 30 years of leadership across multiple industries and numerous countries, Gregg’s experience will...
May 9, 2022 - Thomas Weimbs, PhD & Jessianna Saville, RDN Autosomal dominant polycystic kidney disease (PKD) is a common genetic disorder with limited drug therapy options. PKD progresses relentlessly leading to dramatic and often painful kidney and liver...
Santa Barbara, CA, USA | April 27, 2023 Santa Barbara Nutrients (SBN) is delighted to announce the appointment of Mr. Glenn Frommer to SBN’s Board of Directors which expands the Board to five members. Glenn will leverage the experience from his nearly 40 years of...
Good day! I just would like to give you a huge thumbs up for your great info youve got right here on this post. I will be coming back to your website for more soon.
I was extremely pleased to discover this great site. I want to to thank you for ones time just for this wonderful read!! I definitely liked every little bit of it and i also have you bookmarked to look at new information in your blog.
Not only is it refreshing and taste great, I feel like (as a PKD patient) that we finally have some hope!! And I’m very grateful for that!!